The EU-funded H2020-Marie Sklodowska Curie Action – Innovative Training Network (H2020-MSCA-ITN) EN-ACTI2NG (grant agreement 721358), with partners in the United Kingdom, The Netherlands, Germany, Austria and Spain, is looking for 10 PhD candidates to work on projects aimed at improving T cell mediated immuno-therapy against cancer by the identification and development of new cancer-specific immune receptors (CARs and TCRs) and enhancing their function by identifying and modifying their molecular mechanism of action.